scispace - formally typeset
V

Vasileios Kotsis

Researcher at Aristotle University of Thessaloniki

Publications -  25
Citations -  465

Vasileios Kotsis is an academic researcher from Aristotle University of Thessaloniki. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 3, co-authored 13 publications receiving 79 citations.

Papers
More filters
Journal ArticleDOI

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

Evdoxia Kyriazopoulou, +64 more
- 03 Sep 2021 - 
TL;DR: The SAVE-MORE trial as discussed by the authors evaluated the efficacy and safety of anakinra, an IL-1α/β inhibitor, in 594 patients with COVID-19 at risk of progressing to respiratory failure.
Journal ArticleDOI

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Antonio J. Vallejo-Vaz, +723 more
- 07 Sep 2021 - 
TL;DR: The European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration (FHSC) global registry provides a platform for the global surveillance of familial hypercholesterololaemia through harmonisation and pooling of multinational data as discussed by the authors.
Journal ArticleDOI

Circulating osteopontin: a dual marker of bone destruction and angiogenesis in patients with multiple myeloma

TL;DR: Results support osteopontin as a dual marker of bone destruction and angiogenic activity in myeloma patients and represents a useful biomarker for monitoring myelomas disease activity.
Journal ArticleDOI

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.

Evdoxia Kyriazopoulou, +64 more
- 01 Oct 2021 -